UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effects of quercetin on the bioavailability of doxorubicin in rats: Role of CYP3A4 and P-gp inhibition by quercetin

Archives of Pharmacal Research, 2011, 34(4), , pp.607-613

2011

Volltextzugriff (PDF)

Effect of genistein on the pharmacokinetics of paclitaxel administered orally or intravenously in rats

International journal of pharmaceutics, 2007-06, Vol.337 (1), p.188-193

2007

Volltextzugriff (PDF)

Effects of myricetin, an antioxidant, on the pharmacokinetics of losartan and its active metabolite, EXP-3174, in rats: possible role of cytochrome P450 3A4, cytochrome P450 2C9 and P-glycoprotein inhibition by myricetin

Journal of pharmacy and pharmacology, 2010-07, Vol.62 (7), p.908-914

2010

Volltextzugriff (PDF)

Effects of Quercetin on the Pharmacokinetics of Etoposide after Oral or Intravenous Administration of Etoposide in Rats

Anticancer research, 2009-04, Vol.29 (4), p.1411-1415

2009

Volltextzugriff (PDF)

Effects of epigallocatechin gallate on the oral bioavailability and pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats

Anti-cancer drugs, 2009-08, Vol.20 (7), p.584-588

2009

Volltextzugriff (PDF)

Effects of licochalcone A on the bioavailability and pharmacokinetics of nifedipine in rats: possible role of intestinal CYP3A4 and P-gp inhibition by licochalcone A

Biopharmaceutics & drug disposition, 2014-10, Vol.35 (7), p.382-390

2014

Volltextzugriff (PDF)

Effects of oral curcumin on the pharmacokinetics of intravenous and oral etoposide in rats: possible role of intestinal CYP3A and P-gp inhibition by curcumin

Biopharmaceutics & drug disposition, 2011-05, Vol.32 (4), p.245-251

2011

Volltextzugriff (PDF)

Effects of oral epigallocatechin gallate on the oral pharmacokinetics of verapamil in rats

Biopharmaceutics & drug disposition, 2009-03, Vol.30 (2), p.90-93

2009

Volltextzugriff (PDF)

Enhanced paclitaxel bioavailability after oral administration of pegylated paclitaxel prodrug for oral delivery in rats

International journal of pharmaceutics, 2004-08, Vol.280 (1), p.221-227

2004

Volltextzugriff (PDF)

Effects of Silybinin on the Pharmacokinetics of Tamoxifen and Its Active Metabolite, 4-Hydroxytamoxifen in Rats

Anticancer research, 2010-01, Vol.30 (1), p.79-85

2010

Volltextzugriff (PDF)

Intestinal absorption characteristics of ketoprofen in rats

Biopharmaceutics & drug disposition, 2006-01, Vol.27 (1), p.17-21

2006

Volltextzugriff (PDF)

Pharmacokinetic interaction between oral lovastatin and verapamil in healthy subjects: role of P-glycoprotein inhibition by lovastatin

European journal of clinical pharmacology, 2010-03, Vol.66 (3), p.285-290

2010

Volltextzugriff (PDF)

Drug interaction between oral atorvastatin and verapamil in healthy subjects: effects of atorvastatin on the pharmacokinetics of verapamil and norverapamil

European journal of clinical pharmacology, 2008-05, Vol.64 (5), p.445-449

2008

Volltextzugriff (PDF)

Effects of oral epigallocatechin gallate on the pharmacokinetics of nicardipine in rats

Archives of Pharmacal Research, 2009, 32(12), , pp.1721-1725

2009

Volltextzugriff (PDF)

Effects of efonidipine on the pharmacokinetics and pharmacodynamics of repaglinide: possible role of CYP3A4 and P-glycoprotein inhibition by efonidipine

Journal of pharmacokinetics and pharmacodynamics, 2012-02, Vol.39 (1), p.99-108

2012

Volltextzugriff (PDF)

Effects of simvastatin on the pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, after oral and intravenous administration in rats: possible role of P-glycoprotein and CYP3A4 inhibition by simvastatin

Pharmacological reports, 2011, Vol.63 (6), p.1574-1582

2011

Volltextzugriff (PDF)

Effects of Resveratrol on the Pharmacokinetics of Diltiazem and Its Major Metabolite, Desacetyldiltiazem, in Rats

Cardiovascular therapeutics, 2008, Vol.26 (4), p.269-275

2008

Volltextzugriff (PDF)

The effect of verapamil on the pharmacokinetics of paclitaxel in rats

European journal of pharmaceutical sciences, 2005, Vol.24 (1), p.95-100

2005

Volltextzugriff (PDF)

Effects of oral kaempferol on the pharmacokinetics of tamoxifen and one of its metabolites, 4-hydroxytamoxifen, after oral administration of tamoxifen to rats

Biopharmaceutics & drug disposition, 2008-05, Vol.29 (4), p.245-249

2008

Volltextzugriff (PDF)

Role of monocarboxylic acid transporters in the cellular uptake of NSAIDs

Journal of pharmacy and pharmacology, 2005-09, Vol.57 (9), p.1185-1189

2005

Volltextzugriff (PDF)

Effects of morin on the pharmacokinetics of etoposide in rats

Biopharmaceutics & drug disposition, 2007-04, Vol.28 (3), p.151-156

2007

Volltextzugriff (PDF)

Effects of morin on the pharmacokinetics of nicardipine after oral and intravenous administration of nicardipine in rats

Journal of pharmacy and pharmacology, 2008-05, Vol.60 (5), p.625-629

2008

Volltextzugriff (PDF)

Effect of hesperidin on the oral pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, in rats

Journal of pharmacy and pharmacology, 2009-06, Vol.61 (6), p.825-829

2009

Volltextzugriff (PDF)

Enhanced bioavailability of verapamil after oral administration with hesperidin in rats

Archives of Pharmacal Research, 2008, 31(4), , pp.518-522

2008

Volltextzugriff (PDF)

The effect of quercetin on the pharmacokinetics of verapamil and its major metabolite, norverapamil, in rabbits

Journal of pharmacy and pharmacology, 2004-12, Vol.56 (12), p.1537-1542

2004

Volltextzugriff (PDF)

1 – 25 von 293

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(265)
Mit Volltextzugriff
(218)

Publikationsform

Artikel
(292)
Dissertationen
(1)

Sprache

Englisch
(172)
Koreanisch
(120)

Erscheinungsjahr

n.n

Thema

Science & Technology
(142)
Life Sciences & Biomedicine
(132)
Pharmacology & Pharmacy
(113)
Male
(99)
Pharmacokinetics
(95)
Animals
(89)
Rats
(88)
Rats, Sprague-Dawley
(66)
Bioavailability
(61)
Biological Availability
(53)
약학
(53)
Administration, Oral
(52)
Area Under Curve
(50)
Drug Interactions
(43)
Biological And Medical Sciences
(42)
Medical Sciences
(42)
Chemistry, Medicinal
(37)
Humans
(35)
Pharmacology. Drug Treatments
(34)
Chromatography, High Pressure Liquid
(33)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effects of quercetin on the bioavailability of doxorubicin in rats: Role of CYP3A4 and P-gp inhibition by quercetin

Effect of genistein on the pharmacokinetics of paclitaxel administered orally or intravenously in rats

Effects of myricetin, an antioxidant, on the pharmacokinetics of losartan and its active metabolite, EXP-3174, in rats: possible role of cytochrome P450 3A4, cytochrome P450 2C9 and P-glycoprotein inhibition by myricetin

Effects of Quercetin on the Pharmacokinetics of Etoposide after Oral or Intravenous Administration of Etoposide in Rats

Effects of epigallocatechin gallate on the oral bioavailability and pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats

Effects of licochalcone A on the bioavailability and pharmacokinetics of nifedipine in rats: possible role of intestinal CYP3A4 and P-gp inhibition by licochalcone A

Effects of oral curcumin on the pharmacokinetics of intravenous and oral etoposide in rats: possible role of intestinal CYP3A and P-gp inhibition by curcumin

Effects of oral epigallocatechin gallate on the oral pharmacokinetics of verapamil in rats

Enhanced paclitaxel bioavailability after oral administration of pegylated paclitaxel prodrug for oral delivery in rats

Effects of Silybinin on the Pharmacokinetics of Tamoxifen and Its Active Metabolite, 4-Hydroxytamoxifen in Rats

Intestinal absorption characteristics of ketoprofen in rats

Pharmacokinetic interaction between oral lovastatin and verapamil in healthy subjects: role of P-glycoprotein inhibition by lovastatin

Drug interaction between oral atorvastatin and verapamil in healthy subjects: effects of atorvastatin on the pharmacokinetics of verapamil and norverapamil

Effects of oral epigallocatechin gallate on the pharmacokinetics of nicardipine in rats

Effects of efonidipine on the pharmacokinetics and pharmacodynamics of repaglinide: possible role of CYP3A4 and P-glycoprotein inhibition by efonidipine

Effects of simvastatin on the pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, after oral and intravenous administration in rats: possible role of P-glycoprotein and CYP3A4 inhibition by simvastatin

Effects of Resveratrol on the Pharmacokinetics of Diltiazem and Its Major Metabolite, Desacetyldiltiazem, in Rats

The effect of verapamil on the pharmacokinetics of paclitaxel in rats

Effects of oral kaempferol on the pharmacokinetics of tamoxifen and one of its metabolites, 4-hydroxytamoxifen, after oral administration of tamoxifen to rats

Role of monocarboxylic acid transporters in the cellular uptake of NSAIDs

Effects of morin on the pharmacokinetics of etoposide in rats

Effects of morin on the pharmacokinetics of nicardipine after oral and intravenous administration of nicardipine in rats

Effect of hesperidin on the oral pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, in rats

Enhanced bioavailability of verapamil after oral administration with hesperidin in rats

The effect of quercetin on the pharmacokinetics of verapamil and its major metabolite, norverapamil, in rabbits

Suchergebnisse filtern